SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin receives UFDA approval for Gatifloxacin ophthalmic solution

30 Aug 2013 Evaluate

Lupin has received United States Food and Drugs Administration (UFDA)’s approval for Gatifloxacin 0.5% ophthalmic solution. Gatifloxacin, a broad-spectrum antibiotic, is formulated as eye drops for ophthalmic use. It is indicated for the treatment of bacterial conjunctivitis and keratitis (including corneal ulcer) and is a fluoroquinoline antibacterial antibiotic that acts by inhibiting bacterial topoisomerases II and IV, enzymes which are essential for bacterial DNA replication, transcription and translation. Earlier, in July the company received FDA tentative approval for Gatifloxacin ophthalmic solution.

Recently, Lupin’s - US subsidiary, Lupin Pharmaceuticals, Inc. (LPI) has received final approval for its Rifampin Capsules USP, 150 mg and 300 mg strengths from the United States Food and Drugs Administration (USFDA).

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations and APIs globally.

Lupin Share Price

2377.90 -81.85 (-3.33%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×